Categories: News

LEPAS Shines at the 2025 Chery International User Summit, Where “Technology Meets Elegance” to Define a New Way of Life

WUHU, China, Nov. 3, 2025 /PRNewswire/ — From October 17 to 21, the 2025 Chery International User Summit held in Wuhu, Anhui. As Chery Group’s all-new new energy brand, LEPAS presented its brand character through a series of activities. In the presence of global media and distributor representatives, LEPAS showcased its positioning as the “Preferred Brand for Elegant Mobility Life.”

- Advertisement -

Elegant Driving Experience: Long-Distance and Interactive Testing

- Advertisement -

The Global Journey of Elegant Driving (China Stop) and Fun Test Drive allowed guests to experience the LEPAS L8 across multiple driving scenes over 900 kilometers. Participants tested range, intelligent driving, comfort, and adaptability. In the Fun Test Drive, interactive sessions such as straight-line acceleration and slalom highlighted the LEPAS L8’s precise handling and power control. Guests also experienced Automatic Parking Assist (APA) and Remote Parking Assist (RPA), while the Vehicle-to-Load (V2L) function powered coffee machines and grills on-site. A storage treasure-hunt game showcased the vehicle’s interior design, illustrating “Elegant Technology for daily life.”

- Advertisement -

Elegant Way of LEPAS Debuts: The World’s First LEPAS Elegant Lifestyle House and Brand Showcase Define the Essence of “Elegance”

- Advertisement -

The world’s first LEPAS Elegant Lifestyle House also opened during the summit. The space integrated LEPAS L8, LEPAS L6, and LEPAS L4 into three immersive scenes— “LEPAS Space,” “Memory Lane,” and “Time Café.” It attracted numerous public figures, including Ban Ki-moon, the 8th Secretary-General of the United Nations; Ybg. Mr. NG KAI SENG, Minister-Counsellor of the Embassy of Malaysia in China; JeryL Lee, Malaysian singer; and Sanly Liu, Miss Universe Indonesia 2025.

- Advertisement -

At the LEPAS Brand Showcase & Elegant Technology Launch, the brand unveiled its technological cornerstone—LEPAS Elegant Technology—and announced the Global Distribution Agreement Signing Ceremony and Global Elegant Lifestyle Partner Program, marking a new chapter in its globalization.

- Advertisement -

Safety and Ecosystem: The Foundation of Confidence

- Advertisement -

During the summit, LEPAS held its first open safety test for LEPAS L8, including Bottom Scraping, Fording Obstacle, and Rollover Tests, demonstrating its five-star safety standards and uncompromising elegance built on safety. Together with Chery Group’s AiMOGA Robot and the ecosystem exhibition covering diverse lifestyle scenarios, LEPAS illuminated the summit and set a new benchmark for Elegant Driving in the new energy era.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2811327/LEPAS_Shines_at_the_2025_Chery_International_User_Summit.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/lepas-shines-at-the-2025-chery-international-user-summit-where-technology-meets-elegance-to-define-a-new-way-of-life-302602316.html

- Advertisement -

Recent Posts

FemiCore (Official Website & Authenticity Notice 2026) Counterfeit Risks and What Consumers Should Know

New York City, NY, June 13, 2026 (GLOBE NEWSWIRE) -- The women's health supplement market…

16 hours ago

Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance

BEIJING, June 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Hitch Open Ping-Pong Embodied AI Challenge…

16 hours ago

Crypto News Today: AlphaPepe Unveils AlphaSwap Early Access as Bitcoin Price Prediction Eyes $250,000

MONACO, June 12, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after…

16 hours ago

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a…

18 hours ago

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI…

19 hours ago

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

June 13, 2026 07:30 ET  | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3…

19 hours ago